InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-37.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Hill Barbara B, 董事. Insider active across 2 companies, notably Integra Lifesciences Holdings CORP. In total, 7 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €917k. History available since 14 May 2021. The latest transaction was filed on 9 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Hill Barbara B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
6,939 股0Common StockSEC:0000917520-25-000046:0
36,350 股@ US$27.3952100.0% 占其流量Common StockSEC:0000917520-24-000075:0
标准退出：2024年8月19日 (T+90)
3,163 股0Common StockSEC:0000917520-24-000068:0
1,631 股0Common StockSEC:0001209191-23-029801:0
1,265 股0Common StockSEC:0001209191-22-029716:0
1,060 股0Common StockSEC:0001209191-21-033131:0
8,800 股Common StockSEC:0001179110-16-018645:0
7 条申报中的 7 条
About Hill Barbara B
Barbara B. Hill is a Director at Integra LifeSciences Holdings Corp. In this role, she participates in the governance of the company, providing her expertise in strategy and healthcare. Barbara plays a key role in the strategic direction of Integra, a company specializing in medical devices.
